Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human NeuroD2 ELISA Kit (AC3600)
Cat.#: ASET-2189
Specifications
Description Human NeuroD2 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human NeuroD2 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.021 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.5-8 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1362 Mouse Urocortin ELISA Kit (AC2773) Quantitative inquiry ASET-1658 ACTH ELISA Kit (AC3069) Quantitative inquiry ASET-1558 Human Prealbumin ELISA Kit (AC2969) Quantitative inquiry ASET-1627 Mouse AGRP ELISA Kit (AC3038) Quantitative inquiry ASET-1286 Mouse Prion Protein PrP ELISA Kit (AC2697) Quantitative inquiry ASET-1586 Mouse GFAP ELISA Kit (AC2997) Quantitative inquiry ASET-2302 Human KCNN4 ELISA Kit (AC3713) Quantitative inquiry ASET-1283 Human Malondialdehyde ELISA Kit (AC2694) Quantitative inquiry ASET-1984 Mouse PGP9.5 ELISA Kit (AC3395) Quantitative inquiry ASET-2286 Human TPH2 ELISA Kit (AC3697) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket